|Ungraded position statement: The duration of GC therapy for GPA/MPA should be guided by the patientâ€™s clinical condition, preferences, and values.|27, 33|Low to moderate|
|Treatment of disease relapse| | |
|Recommendation: For patients with GPA/MPA who have experienced relapse with severe disease manifestations and are not receiving rituximab for remission maintenance, we conditionally recommend treatment with rituximab over cyclophosphamide for remission re-induction.|28|Low|